(Approval Lapsed 19/3/19) ZOLEDRONIC ACID 4mg/5mL Concentrate for Solution for Infusion (Claris Lifesciences)
Section 19A approved medicine
(Approval Lapsed 19/3/19) ZOLEDRONIC ACID 4mg/5mL Concentrate for Solution for Infusion (Claris Lifesciences)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Lapsed
Medicines in short supply/unavailable
APO-Zoledronic Acid 4mg/5mL concentrated injection vial - ARTG 190337
Indication(s)
- Prevention of skeletal-related events (pathological fracture, spinal cord compression, radiation to bone or surgery to bone) in adult patients with advanced malignancies involving bone.
- Treatment of adult patients with tumour-induced hypercalcaemia.
Additional information